The microbiome of the oral mucosa in irritable bowel syndrome

Gut Microbes

Volumn 7, Issue 4, 2016, Pages 286-301

  Fourie, Nicolaas H ^a   Wang, Dan ^a   Abey, Sarah K ^a   Sherwin, LeeAnne B ^a   Joseph, Paule V ^a   Rahim Williams, Bridgett ^b   Ferguson, Eric G ^a   Henderson, Wendy A ^a  

^a NATIONAL INSTITUTE OF NURSING RESEARCH   (United States)

^b NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES   (United States)

Author keywords

irritable bowel syndrome; microbiome; mucosa; oral; overweight; visceral pain

Indexed keywords

ADULT; ARTICLE; BACILLACEAE; BACILLUS; BODY WEIGHT; BRADYRHIZOBIACEAE; CLINICAL ARTICLE; COLON FLORA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIRMICUTES; GEMELLA; HUMAN; IRRITABLE COLON; MALE; MICROARRAY ANALYSIS; MICROBIOME; MORAXELLACEAE; MOUTH FLORA; MOUTH MUCOSA; MYCOPLASMATACEAE; NONHUMAN; OBESITY; PAIN SEVERITY; SPECIES RICHNESS; STREPTOMYCETACEAE; VISCERAL PAIN; ABDOMINAL PAIN; BACTERIUM; CLASSIFICATION; FECES; GENETICS; INTESTINE MUCOSA; IRRITABLE BOWEL SYNDROME; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; PARASITOLOGY; PATHOLOGY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ABDOMINAL PAIN; ADULT; BACTERIA; FECES; FEMALE; HUMANS; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; MICROBIOTA; MOUTH MUCOSA; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84963543182     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2016.1162363     Document Type: Article

References (77)

1. D.A.Drossman, M.Camilleri, E.A.Mayer, W.E.Whitehead. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123(6):2108-31; PMID:12454866; http://dx.doi.org/10.1053/gast.2002.37095
2. G.Major, R.Spiller. Irritable bowel syndrome, inflammatory bowel disease and the microbiome.” Curr Opin Endocrinol Diabetes Obes 2014; 21(1):15-21; PMID:24296462; http://dx.doi.org/10.1097/MED.0000000000000032
3. F.Shanahan, E.M.M.Quigley. Manipulation of the Microbiota for Treatment of IBS and IBD—Challenges and Controversies. Gastroenterology 2014; 146(6):1554-63; PMID:24486051; http://dx.doi.org/10.1053/j.gastro.2014.01.050
4. I.M.Carroll, T.Ringel-Kulka, J.P.Siddle, Y.Ringel. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2012; 24(6):521-30; PMID:22339879; http://dx.doi.org/10.1111/j.1365-2982.2012.01891.x
5. P.J.Kennedy, J.F.Cryan, T.G.Dinan, G.Clarke. Irritable bowel syndrome:a microbiome-gut-brain axis disorder? World J Gastroenterol 2014; 20(39):14105-25; PMID:25339800; http://dx.doi.org/10.3748/wjg.v20.i39.14105
6. K.J.Lee, J.Tack. Altered intestinal microbiota in irritable bowel syndrome. Neurogastroenterol Motil 2010; 22(5):493-8; PMID:20414959; http://dx.doi.org/10.1111/j.1365-2982.2010.01482.x
7. K.Ponnusamy, J.N.Choi, J.Kim, S.Y.Lee, C.H.Lee. Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol 2011; 60(Pt 6):817-27; PMID:21330412; http://dx.doi.org/10.1099/jmm.0.028126-0
8. M.J.Docktor, B.J.Paster, S.Abramowicz, J.Ingram, Y.E.Wang, M.Correll, H.Jiang, S.L.Cotton, A.S.Kokaras, A.Bousvaros. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2012; 18(5):935-42; PMID:21987382; http://dx.doi.org/10.1002/ibd.21874
9. J.Rautava, L.J.Pinnell, L.Vong, N.Akseer, A.Assa, P.M.Sherman. Oral Microbiome Composition Changes in Mouse Models of Colitis. J Gastroenterol Hepatol 2014; 2(10):12713.
10. H.S.Said, W.Suda, S.Nakagome, H.Chinen, K.Oshima, S.Kim, R.Kimura, A.Iraha, H.Ishida, J.Fujita, Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers. DNA Res 2014; 21(1):15-25; PMID:24013298; http://dx.doi.org/10.1093/dnares/dst037
11. J.Ahn, C.Y.Chen, R.B.Hayes. Oral microbiome and oral and gastrointestinal cancer risk.” Cancer Causes Control 2012; 23(3):399-404; PMID:22271008; http://dx.doi.org/10.1007/s10552-011-9892-7
12. X.Li, K.M.Kolltveit, L.Tronstad, I.Olsen. Systemic Diseases Caused by Oral Infection. Clin Microbiol Rev 2000; 13(4):547-58; PMID:11023956; http://dx.doi.org/10.1128/CMR.13.4.547-558.2000
13. E.Zaura, E.A.Nicu, B.P.Krom, B.J.Keijser. Acquiring and maintaining a normal oral microbiome:current perspective. Front Cell Infect Microbiol 2014; 4:85; PMID:25019064; http://dx.doi.org/10.3389/fcimb.2014.00085
14. E.K.Costello, C.L.Lauber, M.Hamady, N.Fierer, J.I.Gordon, R.Knight. Bacterial community variation in human body habitats across space and time. Science 2009; 326(5960):1694-7; PMID:19892944; http://dx.doi.org/10.1126/science.1177486
15. V.Lazarevic, K.Whiteson, D.Hernandez, P.Francois, J.Schrenzel. Study of inter- and intra-individual variations in the salivary microbiota.” BMC Genomics 2010; 11:523; PMID:20920195; http://dx.doi.org/10.1186/1471-2164-11-523
16. I.A.Rasiah, L.Wong, S.A.Anderson, C.H.Sissons. Variation in bacterial DGGE patterns from human saliva:over time, between individuals and in corresponding dental plaque microcosms. Arch Oral Biol 2005; 50(9):779-87; PMID:15970209; http://dx.doi.org/10.1016/j.archoralbio.2005.02.001
17. W.G.Wade. The oral microbiome in health and disease. Pharmacol Res 2013; 69(1):137-43; PMID:23201354; http://dx.doi.org/10.1016/j.phrs.2012.11.006
18. T.Ding, P.D.Schloss. Dynamics and associations of microbial community types across the human body. Nature 2014; 509(7500):357-60; PMID:24739969; http://dx.doi.org/10.1038/nature13178
19. B.Wolff, T.Berger, C.Frese, R.Max, N.Blank, H.M.Lorenz, D.Wolff. Oral status in patients with early rheumatoid arthritis:a prospective, case-control study. Rheumatology 2014; 53(3):526-31; PMID:24273047; http://dx.doi.org/10.1093/rheumatology/ket362
20. Y.W.Han, X.Wang. Mobile microbiome:oral bacteria in extra-oral infections and inflammation. J Dent Res 2013; 92(6):485-91; PMID:23625375; http://dx.doi.org/10.1177/0022034513487559
21. R.Francavilla, D.Ercolini, M.Piccolo, L.Vannini, S.Siragusa, F.De Filippis, I.De Pasquale, R.Di Cagno, M.Di Toma, G.Gozzi, Salivary microbiota and metabolome associated with celiac disease. Appl Environ Microbiol 2014; 80(11):3416-25; PMID:24657864; http://dx.doi.org/10.1128/AEM.00362-14
22. J.M.Goodson, D.Groppo, S.Halem, E.Carpino. Is Obesity an Oral Bacterial Disease? J Dent Res 2009; 88(6):519-23; PMID:19587155; http://dx.doi.org/10.1177/0022034509338353
23. Y.Wang, J.Xue, X.Zhou, M.You, Q.Du, X.Yang, J.He, J.Zou, L.Cheng, M.Li, Oral microbiota distinguishes acute lymphoblastic leukemia pediatric hosts from healthy populations. PLoS One 2014; 9(7):e102116; PMID:2502546
24. N.Yeoh, J.P.Burton, P.Suppiah, G.Reid, S.Stebbings. The role of the microbiome in rheumatic diseases. Curr Rheumatol Rep 2013; 15(3):012-0314; http://dx.doi.org/10.1007/s11926-012-0314-y
25. O.Koren, A.Spor, J.Felin, F.Fåk, J.Stombaugh, V.Tremaroli, C.J.Behre, R.Knight, B.Fagerberg, R.E.Ley Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A 2011; 108(Supplement 1):4592-8; PMID:20937873; http://dx.doi.org/10.1073/pnas.1011383107
26. X.Li, H.F.Tse, K.H.Yiu, L.S.Li, L.Jin. Effect of periodontal treatment on circulating CD34(+) cells and peripheral vascular endothelial function:a randomized controlled trial. J Clin Periodontol 2011; 38(2):148-56; PMID:21133981; http://dx.doi.org/10.1111/j.1600-051X.2010.01651.x
27. M.S.Tonetti, F.D'Aiuto, L.Nibali, A.Donald, C.Storry, M.Parkar, J.Suvan, A.D.Hingorani, P.Vallance, J.Deanfield. Treatment of Periodontitis and Endothelial Function.” N Engl J Med 2007; 356(9):911-20; PMID:17329698; http://dx.doi.org/10.1056/NEJMoa063186
28. W.J.Teeuw, V.E.Gerdes, B.G.Loos. Effect of periodontal treatment on glycemic control of diabetic patients:a systematic review and meta-analysis. Diabetes Care 2010; 33(2):421-7; PMID:20103557; http://dx.doi.org/10.2337/dc09-1378
29. A.Moura Foz, G.Alexandre Romito, C.Manoel Bispo, C.Luciancencov Petrillo, K.Patel, J.Suvan, F.D'Aiuto. Periodontal therapy and biomarkers related to cardiovascular risk. Minerva Stomatol 2010; 59(5):271-83; PMID:20502435
30. J.Jalanka, A.Salonen, S.Fuentes, W.M.de Vos. Microbial Signatures in Post-Infectious Irritable Bowel Syndrome – Towards Patient Stratification for Improved Diagnostics and Treatment. Gut Microbes 2015; 6:364-9; PMID:26512631
31. E.A.Mayer, T.Savidge, R.J.Shulman. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 2014; 146(6):1500-12; PMID:24583088; http://dx.doi.org/10.1053/j.gastro.2014.02.037
32. M.Pozuelo, S.Panda, A.Santiago, S.Mendez, A.Accarino, J.Santos, F.Guarner, F.Azpiroz, C.Manichanh. Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci Rep 2015; 5:12693; http://dx.doi.org/10.1038/srep12693
33. D.M.Saulnier, K.Riehle, T.A.Mistretta, M.A.Diaz, D.Mandal, S.Raza, E.M.Weidler, X.Qin, C.Coarfa, A.Milosavljevic, Gastrointestinal Microbiome Signatures of Pediatric Patients With Irritable Bowel Syndrome. Gastroenterology 2011; 141(5):1782-1791; PMID:21741921; http://dx.doi.org/10.1053/j.gastro.2011.06.072
34. K.Moritani, T.Takeshita, Y.Shibata, T.Ninomiya, Y.Kiyohara, Y.Yamashita. Acetaldehyde production by major oral microbes. Oral Dis 2015; 21(6):748-754; PMID:25809116; http://dx.doi.org/10.1111/odi.12341
35. T.Chinen, P.Y.Volchkov, A.V.Chervonsky, A.Y.Rudensky. A critical role for regulatory T cell-mediated control of inflammation in the absence of commensal microbiota. J Exp Med 2010; 207(11):2323-30; PMID:20921284; http://dx.doi.org/10.1084/jem.20101235
36. E.Slack, S.Hapfelmeier, B.Stecher, Y.Velykoredko, M.Stoel, M.A.E.Lawson, M.B.Geuking, B.Beutler, T.F.Tedder, W.-D.Hardtet al. Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism. Science 2009; 325(5940):617-20; PMID:19644121; http://dx.doi.org/10.1126/science.1172747
37. L.E.Tailford, E.H.Crost, D.Kavanaugh, N.Juge. Mucin glycan foraging in the human gut microbiome. Front Genet 2015; 6:81; PMID:25852737; http://dx.doi.org/10.3389/fgene.2015.00081
38. A.A.Stone, J.E.Broderick. Obesity and Pain Are Associated in the United States. Obesity 2012; 20(7):1491-5; PMID:22262163; http://dx.doi.org/10.1038/oby.2011.397
39. L.J.Wright, E.Schur, C.Noonan, S.Ahumada, D.Buchwald, N.Afari. Chronic Pain, Overweight, and Obesity:Findings from a Community-Based Twin Registry. J Pain 2010; 11(7):628-35; PMID:20338816; http://dx.doi.org/10.1016/j.jpain.2009.10.004
40. R.A.Astita, O.A.Tashani, D.Sharp, M.I.Johnson. Argument for the need of investigation of the relationship between body fatness and experimental pain sensitivity. Libyan J Med 2015; 10:28457 ; PMID:26085491; http://dx.doi.org/10.3402/ljm.v10.28457
41. C.-H.Kim, C.A.Luedtke, A.Vincent, J.M.Thompson, T.H.Oh. Association of body mass index with symptom severity and quality of life in patients with fibromyalgia. Arthritis Care Res 2012; 64(2):222-8; PMID:21972124; http://dx.doi.org/10.1002/acr.20653
42. P.Ravn, R.Frederiksen, A.P.Skovsen, L.L.Christrup, M.U.Werner. Prediction of pain sensitivity in healthy volunteers.” J Pain Res 2012; 5:313-26; PMID:23055774; http://dx.doi.org/10.2147/JPR.S33925
43. F.L.Heggendorn, L.Souza Gonçalves, E.P.Dias, A.Silva Junior, M.M.Galvão, M.T.S.Lutterbach. Detection of sulphate-reducing bacteria in human saliva. Acta Odontol Scand 2013; 71(6):1458-1463; PMID:23638810; http://dx.doi.org/10.3109/00016357.2013.770163
44. J.Loubinoux, J.-P.Bronowicki, I.A.C.Pereira, J.-L.Mougenel, A.E.Le Faou. Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases; 2002
45. V.Shankar, R.Agans, B.Holmes, M.Raymer, O.Paliy. Do gut microbial communities differ in pediatric IBS and health? Gut Microbes 2013; 4(4):347-52; PMID:23674073; http://dx.doi.org/10.4161/gmic.24827
46. I.B.Jeffery, P.W.O'Toole, L.Öhman, M.J.Claesson, J.Deane, E.M.M.Quigley, M.Simrén. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012; 61(7):997-1006; PMID:22180058; http://dx.doi.org/10.1136/gutjnl-2011-301501
47. M.Rajilic-Stojanovic, E.Biagi, H.G.Heilig, K.Kajander, R.A.Kekkonen, S.Tims, W.M.de Vos. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141(5):1792-801; PMID:21820992; http://dx.doi.org/10.1053/j.gastro.2011.07.043
48. L.Rigsbee, R.Agans, V.Shankar, H.Kenche, H.J.Khamis, S.Michail, O.Paliy. Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2012; 107(11):1740-51; PMID:22986438; http://dx.doi.org/10.1038/ajg.2012.287
49. G.L.Nicolson, M.Y.Nasralla, A.R.Franco, K.D.Meirleir, N.L.Nicolson, R.Ngwenya, J.Haier. Role of Mycoplasmal Infections in Fatigue Illnesses. J Chronic Fatigue Syndrome 2000; 6(3-4):23-39; http://dx.doi.org/10.1300/J092v06n03_03
50. L.Hun. Original Research:Bacillus coagulans Significantly Improved Abdominal Pain and Bloating in Patients with IBS. Postgrad Med 2009; 121(2):119-24; PMID:19332970; http://dx.doi.org/10.3810/pgm.2009.03.1984
51. M.L.Ramirez-Chavarin, C.Wacher, C.A.Eslava-Campos. Probiotic potential of thermotolerant lactic acid bacteria strains isolated from cooked meat products. Int Food Res J 2013; 20:991-1000.
52. O.A.Zhurylo, S.A.Turliun, T.Drozd. [A biological model study of the effect of Aerococcus viridans on pathogenic bacteria]. Mikrobiol Z 1998; 60(3):56-62; PMID:9785800
53. C.Charrier, G.J.Duncan, M.D.Reid, G.J.Rucklidge, D.Henderson, P.Young, V.J.Russell, R.I.Aminov, H.J.Flint, P.Louis). A novel class of CoA-transferase involved in short-chain fatty acid metabolism in butyrate-producing human colonic bacteria. Microbiology 2006; 152(Pt 1):179-85; PMID:16385128; http://dx.doi.org/10.1099/mic.0.28412-0
54. S.H.Duncan, A.Barcenilla, C.S.Stewart, S.E.Pryde, H.J.Flint). Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol 2002; 68(10):5186-90; PMID:12324374; http://dx.doi.org/10.1128/AEM.68.10.5186-5190.2002
55. P.Louis, S.H.Duncan, S.I.McCrae, J.Millar, M.S.Jackson, H.J.Flint. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J Bacteriol 2004; 186(7):2099-106; PMID:15028695; http://dx.doi.org/10.1128/JB.186.7.2099-2106.2004
56. A.McIntyre, P.R.Gibson, G.P.Young. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 1993; 34(3):386-91; PMID:8386131; http://dx.doi.org/10.1136/gut.34.3.386
57. N.Singh, A.Gurav, S.Sivaprakasam, E.Brady, R.Padia, H.Shi, M.Thangaraju, P.D.Prasad, S.Manicassamy, D.H.Munn, Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014; 40(1):128-39; PMID:24412617; http://dx.doi.org/10.1016/j.immuni.2013.12.007
58. E.F.Murphy, P.D.Cotter, S.Healy, T.M.Marques, O.O'Sullivan, F.Fouhy, S.F.Clarke, P.W.O'Toole, E.M.Quigley, C.Stanton, Composition and energy harvesting capacity of the gut microbiota:relationship to diet, obesity and time in mouse models. Gut 2010; 59(12):1635-42; PMID:20926643; http://dx.doi.org/10.1136/gut.2010.215665
59. A.Santacruz, A.Marcos, J.Warnberg, A.Marti, M.Martin-Matillas, C.Campoy, L.A.Moreno, O.Veiga, C.Redondo-Figuero, J.M.Garagorri, Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring) 2009; 17(10):1906-15; PMID:19390523; http://dx.doi.org/10.1038/oby.2009.112
60. P.Piombino, A.Genovese, S.Esposito, L.Moio, P.P.Cutolo, A.Chambery, V.Severino, E.Moneta, D.P.Smith, S.M.Owens, Saliva from Obese Individuals Suppresses the Release of Aroma Compounds from Wine. PLoS One 2014; 9(1):e85611; PMID:24465618; http://dx.doi.org/10.1371/journal.pone.0085611
61. C.J.Adler, K.Dobney, L.S.Weyrich, J.Kaidonis, A.W.Walker, W.Haak, C.J.A.Bradshaw, G.Townsend, A.Soltysiak, K.W.Alt, Sequencing ancient calcified dental plaque shows changes in oral microbiota with dietary shifts of the Neolithic and Industrial revolutions. Nat Genet 2013; 45(4):450-5; PMID:23416520; http://dx.doi.org/10.1038/ng.2536
62. D.Ercolini, R.Francavilla, L.Vannini, F.De Filippis, T.Capriati, R.Di Cagno, G.Iacono, M.De Angelis, M.Gobbetti. From an imbalance to a new imbalance:Italian-style gluten-free diet alters the salivary microbiota and metabolome of African celiac children. Sci Rep 2015; 5:18571; PMID:26681599; http://dx.doi.org/10.1038/srep18571
63. V.Lecomte, N.O.Kaakoush, C.A.Maloney, M.Raipuria, K.D.Huinao, H.M.Mitchell, M.J.Morris.Changes in Gut Microbiota in Rats Fed a High Fat Diet Correlate with Obesity-Associated Metabolic Parameters.” PLoS ONE 2015; 10(5):e0126931; PMID:25992554; http://dx.doi.org/10.1371/journal.pone.0126931
64. G.D.Wu, J.Chen, C.Hoffmann, K.Bittinger, Y.-Y.Chen, S.A.Keilbaugh, M.Bewtra, D.Knights, W.A.Walters, R.Knight, Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes. Science 2011; 334(6052):105-8; PMID:21885731; http://dx.doi.org/10.1126/science.1208344
65. S.Baumgartner, T.Imfeld, O.Schicht, C.Rath, R.E.Persson, G.R.Persson. The impact of the stone age diet on gingival conditions in the absence of oral hygiene. J Periodontol 2009; 80(5):759-68; PMID:19405829; http://dx.doi.org/10.1902/jop.2009.080376
66. A.Schwiertz, D.Taras, K.Schäfer, S.Beijer, N.A.Bos, C.Donus, P.D.Hardt. Microbiota and SCFA in Lean and Overweight Healthy Subjects. Obesity 2010; 18(1):190-5; PMID:19498350; http://dx.doi.org/10.1038/oby.2009.167
67. J.Jalanka-Tuovinen, J.Salojarvi, A.Salonen, O.Immonen, K.Garsed, F.M.Kelly, A.Zaitoun, A.Palva, R.C.Spiller, W.M.de Vos. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut 2014; 63(11):1737-45; PMID:24310267; http://dx.doi.org/10.1136/gutjnl-2013-305994
68. S.C.Ng, E.F.Lam, T.T.Lam, Y.Chan, W.Law, P.C.Tse, M.A.Kamm, J.J.Sung, F.K.Chan, J.C.Wu. Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome. J Gastroenterol Hepatol 2013; 28(10):1624-31; PMID:23800182
69. X.C.Morgan, T.L.Tickle, H.Sokol, D.Gevers, K.L.Devaney, D.V.Ward, J.A.Reyes, S.A.Shah, N.LeLeiko, S.B.Snapper. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012; 13(9):R79; PMID:23013615; http://dx.doi.org/10.1186/gb-2012-13-9-r79
70. E.Mutlu, A.Keshavarzian, P.Engen, C.B.Forsyth, M.Sikaroodi, P.Gillevet. Intestinal Dysbiosis:A Possible Mechanism of Alcohol-Induced Endotoxemia and Alcoholic Steatohepatitis in Rats. Alcohol Clin Exp Res 2009; 33(10):1836-46; PMID:19645728; http://dx.doi.org/10.1111/j.1530-0277.2009.01022.x
71. P.R.Schmidlin, P.Fachinger, G.Tini, S.Graber, B.Seifert, S.Dombrowa, S.Irani. Shared microbiome in gums and the lung in an outpatient population. J Infect 2015; 70(3):255-263; PMID:25445885; http://dx.doi.org/10.1016/j.jinf.2014.10.005
72. Y.Zhang, J.Sun, C.-C.Lin, E.Abemayor, M.B.Wang, D.Wong. The emerging landscape of salivary diagnostics. Oral Health Dent Manag 2014; 13:200-10; PMID:24984623
73. D.A.Drossman, E.Corazziari, M.Delvaux, R.Spiller, N.Talley, W.G.Thompson, W.E.Whitehead. Rome III:The Functional Gastrointestinal Disorders. McLean, VA, Degnon Associates, Inc., 2006
74. W.A.Henderson, R.Shankar, T.J.Taylor, A.Y.Del Valle-Pinero, D.E.Kleiner, K.H.Kim, N.N.Youssef. Inverse relationship of interleukin-6 and mast cells in children with inflammatory and non-inflammatory abdominal pain phenotypes. World J Gastrointest Pathophysiol 2012; 3(6):102-8; PMID:23516176; http://dx.doi.org/10.4291/wjgp.v3.i6.102
75. A.Y.Del Valle-Pinero, L.B.Sherwin, E.M.Anderson, R.M.Caudle, W.A.Henderson. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis. World J Gastroenterol 2015; 21(1):155-63; PMID:25574088; http://dx.doi.org/10.3748/wjg.v21.i1.155
76. T.DeSantis, E.Brodie, J.Moberg, I.Zubieta, Y.Piceno, G.Andersen. High-Density Universal 16S rRNA Microarray Analysis Reveals Broader Diversity than Typical Clone Library When Sampling the Environment. Micro Ecol 2007; 53(3):371-83; PMID:17334858; http://dx.doi.org/10.1007/s00248-006-9134-9
77. C.Lozupone, M.Hamady, R.Knight. UniFrac - An online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics 2006; 7(1):371; PMID:16893466; http://dx.doi.org/10.1186/1471-2105-7-371